Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Anetoderma and its prothrombotic abnormalities.

Agnes Sparsa¹, Jean Charles Piette, Bertrand Wechsler

¹Department of Internal Medicine, University Hospital Pitié, 83 Boulevard de l'Hopital, 75651 Paris Cedex 13, Paris, France.

Journal of the American Academy of Dermatology

|November 26, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory Domains.

Current rheumatology reports·2025

Same author

Interferon-α biological activity is associated with disease activity and risk of flare in cutaneous lupus erythematosus: A monocentric study of 184 patients.

Journal of the American Academy of Dermatology·2025

Same author

Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision Analysis.

Arthritis care & research·2024

Same author

Comparison of patients with isolated cutaneous lupus erythematosus versus systemic lupus erythematosus with cutaneous lupus erythematosus as the sole clinical feature: A monocentric study of 149 patients.

Journal of the American Academy of Dermatology·2024

Same author

The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.

Arthritis & rheumatology (Hoboken, N.J.)·2023

Same author

2023 ACR/EULAR antiphospholipid syndrome classification criteria.

Annals of the rheumatic diseases·2023

Same journal

Highlights from JAAD Case Reports: September 2026: Repurposing established therapies through biologic insight.

Journal of the American Academy of Dermatology·2026

Same journal

First-Come, First-Served: Ethics of Coordinated Interview Releases.

Journal of the American Academy of Dermatology·2026

Same journal

Ethical Implications of Integrating Artificial Intelligence Tools into Dermatology Electronic Health Records.

Journal of the American Academy of Dermatology·2026

Same journal

Real-world experience with extended deucravacitinib-biologic combination therapy in refractory psoriasis and psoriatic arthritis.

Journal of the American Academy of Dermatology·2026

Same journal

Acute-phase Disease and Super-responder Status Predict Reduced Relapse Risk After Ritlecitinib Withdrawal in Alopecia Areata: A Prospective Real-World Study.

Journal of the American Academy of Dermatology·2026

Same journal

Response to Kvist-Hansen et al. 'Baseline monocytes ≥925/μL appear to represent a rare outlier phenotype rather than a generalizable predictor of adalimumab response in hidradenitis suppurativa.'

Journal of the American Academy of Dermatology·2026

See all related articles

Anetoderma, a skin condition, is often linked to prothrombotic states and antiphospholipid antibodies. Evaluation for these conditions is crucial for patients with anetoderma to manage associated risks.

Area of Science:

Dermatology
Rheumatology
Immunology

Background:

Anetoderma involves skin laxity from dermal elastic tissue loss.
It can be primary or secondary to other skin conditions.
Primary anetoderma is associated with autoimmune diseases and antiphospholipid antibodies.

Purpose of the Study:

To analyze clinical and laboratory data of anetoderma patients.
To investigate associations with connective tissue disorders.

Main Methods:

Retrospective analysis of patients with confirmed anetoderma (1996-2001).
Laboratory screening for prothrombotic abnormalities and lupus indicators.
Clinical and laboratory data review.

Main Results:

Related Experiment Videos

Anetoderma was primary in 9 cases and secondary to lupus profundus in 2.
Prothrombotic abnormalities found in 10 patients (9 primary, 1 secondary).
Antiphospholipid antibodies detected in 9 patients; 4 met antiphospholipid syndrome criteria.

Conclusions:

Patients with anetoderma require evaluation for prothrombotic states.
Awareness of potential risks associated with prothrombotic conditions is essential.